Remophos 667 mg Tablet contains Calcium Acetate and is manufactured by ACI Limited. It is primarily used to control hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease (ESRD). When taken with meals, Calcium Acetate binds to dietary phosphate in the gastrointestinal tract, forming insoluble calcium phosphate complexes that are excreted in the feces, thereby reducing serum phosphate levels